NCT03019822View on ClinicalTrials.gov

Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion Processing

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

August 11, 2018

Study Completion Date

September 4, 2018

Conditions
Healthy
Interventions
DRUG

LSD

100ug per os, single dose

DRUG

MDMA

125mg per os, single dose

DRUG

Amphetamine

40.3mg per os, single dose

DRUG

Placebo

Capsules containing mannitol looking identical to the other drugs

Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT03019822 - Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion Processing | Biotech Hunter | Biotech Hunter